Literature DB >> 11080795

Mechanisms of NF-kappaB activation by the HTLV type 1 tax protein.

X H Li1, R B Gaynor.   

Abstract

The Tax protein encoded by the human T cell leukemia virus type I virus (HTLV-1) activates the expression of both viral genes and cellular genes involved in T lymphocyte growth and proliferation. One of the critical cellular pathways activated by Tax is NF-kappaB. NF-kappaB is normally sequestered in the cytoplasm, bound to a family of inhibitory proteins known as I-kappaB. In contrast to the transient activation of the NF-kappaB pathway seen in response to cytokines, Tax results in constitutive nuclear levels of NF-kappaB. Tax activation of the NF-kappaB pathway is mediated by its ability to enhance the phosphorylation and subsequent degradation of I-kappaB. The persistent activation of the NF-kappaB pathway by Tax is believed to be one of the major events involved in HTLV-1-mediated cellular transformation of T lymphocytes. This review summarizes data exploring the role of Tax in activating the NF-kappaB pathway and discusses our studies to determine the mechanism by which Tax activates the NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080795     DOI: 10.1089/08892220050192994

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.

Authors:  V Richard; M V P Nadella; P L Green; M D Lairmore; G Feuer; J G Foley; T J Rosol
Journal:  Leukemia       Date:  2005-07       Impact factor: 11.528

4.  Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.

Authors:  Ihab Younis; Brenda Yamamoto; Andrew Phipps; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 5.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 6.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

7.  In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.

Authors:  Lisa G Lanigan; Blake E Hildreth; Wessel P Dirksen; Jessica K Simmons; Chelsea K Martin; Jillian L Werbeck; Nandu K Thudi; Tracey L Papenfuss; Prosper N Boyaka; Ramiro E Toribio; Jerrold M Ward; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Am J Pathol       Date:  2020-11-09       Impact factor: 4.307

Review 8.  Move or die: the fate of the Tax oncoprotein of HTLV-1.

Authors:  Julie Lodewick; Isabelle Lamsoul; Françoise Bex
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

9.  Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.

Authors:  N K El-Mallawany; J K Frazer; P Van Vlierberghe; A A Ferrando; S Perkins; M Lim; Y Chu; M S Cairo
Journal:  Blood Cancer J       Date:  2012-04-13       Impact factor: 11.037

10.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.